Search

Search Results
Results 4581 - 4590 of 4658 for multiple sclerosis
  • GTC Biotherapeutics reports total net loss of $1.7M for fourth-quarter 2009
    News - 12 Mar 2010
    GTC Biotherapeutics, Inc. today reported its financial results for the fourth quarter and fiscal year ended January 3, 2010. The total net loss for the fourth quarter was $1.7 million, or $0.09 per...
  • Gross sales of Acorda Therapeutics' ZANAFLEX CAPSULES and tablets increase 9.1% to $58.3M in 2009
    News - 23 Feb 2010
    Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2009.
  • Hexaxim
    Drug - 26 Jun 2025
    Consumer Medicine Information (CMI) about Hexaxim intended for persons living in Australia.
  • Exploring cytokine networks in autoimmune diseases and advances in therapy
    White Paper - 19 Jun 2025
    This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.
  • Lioresal Tablets
    Drug - 12 Jun 2025
    Consumer Medicine Information (CMI) about Lioresal Tablets intended for persons living in Australia.
  • Enbrel
    Drug - 6 Jun 2025
    Consumer Medicine Information (CMI) about Enbrel intended for persons living in Australia.
  • Mersyndol
    Drug - 28 May 2025
    Consumer Medicine Information (CMI) about Mersyndol intended for persons living in Australia.
  • Prodeinextra
    Drug - 16 May 2025
    Consumer Medicine Information (CMI) about Prodeinextra intended for persons living in Australia.
  • Prodeine
    Drug - 16 May 2025
    Consumer Medicine Information (CMI) about Prodeine intended for persons living in Australia.
  • Prodeine Forte
    Drug - 16 May 2025
    Consumer Medicine Information (CMI) about Prodeine Forte intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback